Drägerwerk Q3 2025: Sales & Earnings Surge, Top Forecast Range

• Drägerwerk AG & Co. KGaA reported a 10.1% increase in net sales for Q3 2025, reaching approximately EUR 833 million.
• The medical division's sales grew by 10.2% to around EUR 471 million, while the safety division increased by 9.9% to around EUR 362 million.
• EBIT more than doubled to around EUR 57 million, with an EBIT margin improvement of 3.7 percentage points to 6.8%.
• Order intake rose by 6.9% in Q3 2025, totaling around EUR 856 million, with both divisions contributing to this growth.
• For the first nine months of 2025, net sales increased by 3.7% to around EUR 2,344 million, and order intake rose by 9.0% to around EUR 2,594 million.
• The company expects net sales growth of 3.0 to 5.0% and an EBIT margin of 4.5 to 6.5% for the full year 2025, indicating a positive outlook.

The price of Draegerwerk at the time of the news was 68,95EUR and was up +3,06 % compared with the previous day.
15 minutes after the article was published, the price was 70,40EUR this corresponds to a plus of +2,10 % since publication.
At this time, the index SDAX was at 16.817,89PKT (-1,36 %).

Draegerwerk

-0,30 %

-1,75 %

-11,07 %

-1,03 %

+55,89 %

+59,39 %

-0,44 %

-0,31 %

+1.672,58 %

ISIN:DE0005550636WKN:555063

• Intraday
• 5 Tage
• 1 Monat
• 3M
• 1 Jahr
• 3J
• 5J
• 10J
• Max